| Product Code: ETC6748399 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Neoantigens Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Neoantigens Market Revenues & Volume, 2021 & 2031F |
3.3 China Neoantigens Market - Industry Life Cycle |
3.4 China Neoantigens Market - Porter's Five Forces |
3.5 China Neoantigens Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 China Neoantigens Market Revenues & Volume Share, By Therapeutic Specialty, 2021 & 2031F |
3.7 China Neoantigens Market Revenues & Volume Share, By Line of Therapy, 2021 & 2031F |
3.8 China Neoantigens Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 China Neoantigens Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development for neoantigens in China |
4.2.2 Rising prevalence of cancer cases in China |
4.2.3 Growing awareness and adoption of personalized medicine in the healthcare sector in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of neoantigens in China |
4.3.2 High cost associated with the development and production of neoantigens in China |
5 China Neoantigens Market Trends |
6 China Neoantigens Market, By Types |
6.1 China Neoantigens Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 China Neoantigens Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 China Neoantigens Market Revenues & Volume, By Combination Therapy, 2021- 2031F |
6.1.4 China Neoantigens Market Revenues & Volume, By Mono Therapy, 2021- 2031F |
6.2 China Neoantigens Market, By Therapeutic Specialty |
6.2.1 Overview and Analysis |
6.2.2 China Neoantigens Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.3 China Neoantigens Market Revenues & Volume, By Urinary System Cancer, 2021- 2031F |
6.2.4 China Neoantigens Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.2.5 China Neoantigens Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.6 China Neoantigens Market Revenues & Volume, By Head and Neck Cancer, 2021- 2031F |
6.2.7 China Neoantigens Market Revenues & Volume, By Blood and Bone Marrow Cancer, 2021- 2031F |
6.3 China Neoantigens Market, By Line of Therapy |
6.3.1 Overview and Analysis |
6.3.2 China Neoantigens Market Revenues & Volume, By First Line, 2021- 2031F |
6.3.3 China Neoantigens Market Revenues & Volume, By Second Line, 2021- 2031F |
6.3.4 China Neoantigens Market Revenues & Volume, By Later Lines, 2021- 2031F |
6.4 China Neoantigens Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 China Neoantigens Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Neoantigens Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 China Neoantigens Market Revenues & Volume, By Specialty Centers, 2021- 2031F |
6.4.5 China Neoantigens Market Revenues & Volume, By Others, 2021- 2031F |
7 China Neoantigens Market Import-Export Trade Statistics |
7.1 China Neoantigens Market Export to Major Countries |
7.2 China Neoantigens Market Imports from Major Countries |
8 China Neoantigens Market Key Performance Indicators |
8.1 Number of clinical trials involving neoantigens in China |
8.2 Adoption rate of personalized medicine in cancer treatment in China |
8.3 Investment trends in the biotechnology sector in China |
9 China Neoantigens Market - Opportunity Assessment |
9.1 China Neoantigens Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 China Neoantigens Market Opportunity Assessment, By Therapeutic Specialty, 2021 & 2031F |
9.3 China Neoantigens Market Opportunity Assessment, By Line of Therapy, 2021 & 2031F |
9.4 China Neoantigens Market Opportunity Assessment, By End users, 2021 & 2031F |
10 China Neoantigens Market - Competitive Landscape |
10.1 China Neoantigens Market Revenue Share, By Companies, 2024 |
10.2 China Neoantigens Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here